We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 702

Alcohol Information Partnership Weighs Balanced Approach to New UK Guidelines
  • Shook Hardy & Bacon LLP
  • United Kingdom
  • September 16 2016

Several companies have formed a new group to promote a balanced discussion of alcoholic beverage consumption and address implemen- tation of U.K


NRDC, CSPI File Citizen Petition on Antibiotic Use in Livestock
  • Shook Hardy & Bacon LLP
  • USA
  • September 16 2016

Several consumer-protection groups, including the Natural Resources Defense Council (NRDC) and the Center for Science in the Public Interest (CSPI


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


Energy drink makers target new demographic
  • Shook Hardy & Bacon LLP
  • USA
  • August 23 2013

Although the typical energy drink user is reportedly young and male, a recent news source indicates that a new demographic is emerging as a top


Teens Allegedly Influenced by Soft-Drink Warning Labels
  • Shook Hardy & Bacon LLP
  • USA
  • September 9 2016

Researchers with the University of Pennsylvania Perelman School of Medicine's Center for Health Incentives and Behavioral Economics have authored a


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


French company prevails in dispute with FDA over drug-classification ruling
  • Shook Hardy & Bacon LLP
  • USA
  • October 3 2012

A federal court in the District of Columbia has determined that the Food and Drug Administration (FDA) erred when it classified a combination drug-device product as primarily a drug, thus subjecting its French manufacturer to more burdensome regulatory requirements


AMA Adopts New Policy on Nootropics
  • Shook Hardy & Bacon LLP
  • USA
  • July 28 2016

At its annual meeting held June 10-13, 2016, the American Medical Association (AMA) adopted a new policy targeting nootropics. Nootropicssometimes


CDC Issues Latest Numbers on SSB Consumption
  • Shook Hardy & Bacon LLP
  • USA
  • February 26 2016

The Centers for Disease Control and Prevention (CDC) has released the latest statistics on sugar-sweetened beverage (SSB) consumption in 23 states